Max Aa Ragusi

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2023
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study.

Max A A Ragusi, Bas H M van der Velden, Carla Meeuwis

|Mar 03, 2022
Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA.

M A A Ragusi, B H M van der Velden, M C van Maaren

|Jun 18, 2021
Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancer.

Max Aa Ragusi, Gonneke Ao Winter-Warnars, Jelle Wesseling

|Jul 22, 2020
Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index.

Max A A Ragusi, Claudette E Loo, Bas H M van der Velden

|Jun 04, 2020
Harmonization of Quantitative Parenchymal Enhancement in T1 -Weighted Breast MRI.

Bas H M van der Velden, Michael J van Rijssel, Beatrice Lena

Pageof 1

Frequent Collaborators

1 joint publications

Bas H M van der Velden

1 joint publications

Michael J van Rijssel

1 joint publications

Marielle E P Philippens

1 joint publications

Elizabeth A Morris